Nifty
:
24834.85
Sensex
:
81332.72
428.75 (1.76%)
1292.92 (1.62%)
Nifty
Sensex
:
:
24834.85
81332.72
428.75 (1.76%)
1292.92 (1.62%)

Suven Life Sciences Ltd.

Pharmaceuticals & Drugs - API

Rating :
63/99

BSE: 530239 | NSE: SUVEN

NSE BSE
127.43
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  119.49
  •  127.43
  •  115.83
  •  115.85
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  3065454
  •  3814.05
  •  147.86
  •  60.75

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 3,232.94
  • N/A
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,068.96
  • N/A
  • 11.97

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.27%
  • 1.90%
  • 22.65%
  • FII
  • DII
  • Others
  • 0.45%
  • 1.05%
  • 3.68%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -31.59
  • -4.10
  • -0.42

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 2.02
  • 0.90

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 2.21
  • -4.85

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.10
  • 10.50
  • 13.46

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.83
  • -7.87
  • -13.02

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
2.39
2.61
-8.43%
2.45
3.00
-18.33%
3.06
4.39
-30.30%
3.80
3.54
7.34%
Expenses
32.67
34.13
-4.28%
48.64
54.59
-10.90%
26.57
26.09
1.84%
31.81
24.62
29.20%
EBITDA
-30.29
-31.52
-
-46.19
-51.59
-
-23.51
-21.70
-
-28.01
-21.08
-
EBIDTM
-1,269.94%
-1,207.28%
-1,884.66%
-1,718.42%
-768.33%
-494.71%
-737.79%
-595.65%
Other Income
4.28
5.60
-23.57%
6.07
2.21
174.66%
5.14
0.21
2,347.62%
5.64
0.44
1,181.82%
Interest
0.03
0.05
-40.00%
0.03
0.06
-50.00%
0.04
0.07
-42.86%
0.05
0.10
-50.00%
Depreciation
1.51
1.67
-9.58%
1.60
1.67
-4.19%
1.73
1.62
6.79%
1.66
1.58
5.06%
PBT
-27.54
-27.65
-
-41.77
-51.12
-
-12.68
-23.18
-
-24.09
-16.33
-
Tax
-1.00
0.00
-
0.00
0.00
0
0.00
0.00
0
0.00
0.00
0
PAT
-26.54
-27.65
-
-41.77
-51.12
-
-12.68
-23.18
-
-24.09
-16.33
-
PATM
-1,112.83%
-1,058.83%
-1,704.00%
-1,702.76%
-414.38%
-528.52%
-634.45%
-461.35%
EPS
-1.22
-1.27
-
-1.92
-2.34
-
-0.58
-1.47
-
-1.10
-1.03
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
-
11.69
13.54
11.84
13.48
14.41
285.67
625.26
543.53
499.52
520.86
Net Sales Growth
-
-13.66%
14.36%
-12.17%
-6.45%
-94.96%
-54.31%
15.04%
8.81%
-4.10%
 
Cost Of Goods Sold
-
0.00
0.00
0.00
0.00
0.00
68.74
152.17
147.06
162.64
177.61
Gross Profit
-
11.69
13.54
11.84
13.48
14.41
216.93
473.09
396.47
336.88
343.25
GP Margin
-
100%
100%
100%
100%
100%
75.94%
75.66%
72.94%
67.44%
65.90%
Total Expenditure
-
139.56
139.30
134.09
93.42
130.13
296.65
423.61
414.46
398.18
361.40
Power & Fuel Cost
-
0.26
0.00
0.00
0.00
1.63
19.37
33.56
31.50
29.32
28.04
% Of Sales
-
2.22%
0%
0%
0%
11.31%
6.78%
5.37%
5.80%
5.87%
5.38%
Employee Cost
-
18.99
18.62
21.02
18.53
17.41
36.49
61.27
52.17
35.64
31.75
% Of Sales
-
162.45%
137.52%
177.53%
137.46%
120.82%
12.77%
9.80%
9.60%
7.13%
6.10%
Manufacturing Exp.
-
115.15
115.72
106.53
71.16
103.25
147.09
144.07
153.86
139.49
95.91
% Of Sales
-
985.03%
854.65%
899.75%
527.89%
716.52%
51.49%
23.04%
28.31%
27.92%
18.41%
General & Admin Exp.
-
5.09
4.63
6.09
3.31
4.96
13.48
20.66
19.45
22.48
20.14
% Of Sales
-
43.54%
34.19%
51.44%
24.55%
34.42%
4.72%
3.30%
3.58%
4.50%
3.87%
Selling & Distn. Exp.
-
0.00
0.00
0.00
0.00
0.00
4.89
8.57
7.46
6.73
5.17
% Of Sales
-
0%
0%
0%
0%
0%
1.71%
1.37%
1.37%
1.35%
0.99%
Miscellaneous Exp.
-
0.08
0.33
0.46
0.41
2.88
6.59
3.31
2.95
1.88
5.17
% Of Sales
-
0.68%
2.44%
3.89%
3.04%
19.99%
2.31%
0.53%
0.54%
0.38%
0.53%
EBITDA
-
-127.87
-125.76
-122.25
-79.94
-115.72
-10.98
201.65
129.07
101.34
159.46
EBITDA Margin
-
-1093.84%
-928.80%
-1032.52%
-593.03%
-803.05%
-3.84%
32.25%
23.75%
20.29%
30.61%
Other Income
-
21.13
8.45
1.60
7.75
14.04
27.25
23.27
21.09
19.62
8.58
Interest
-
0.30
0.41
0.67
0.94
0.55
1.91
4.63
5.68
5.88
4.71
Depreciation
-
6.50
6.54
4.39
4.35
4.17
14.20
24.76
21.41
17.50
11.78
PBT
-
-113.54
-124.27
-125.71
-77.47
-106.40
0.16
195.53
123.07
97.58
151.55
Tax
-
-1.00
0.00
0.00
-5.32
-12.18
24.06
71.84
35.88
25.74
42.80
Tax Rate
-
0.94%
0.00%
0.00%
6.87%
11.45%
15037.50%
36.74%
29.15%
26.38%
28.24%
PAT
-
-105.08
-118.27
-122.00
-72.15
-94.22
-23.90
123.69
87.19
71.85
108.75
PAT before Minority Interest
-
-105.08
-118.27
-122.00
-72.15
-94.22
-23.90
123.69
87.19
71.85
108.75
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
-898.89%
-873.49%
-1030.41%
-535.24%
-653.85%
-8.37%
19.78%
16.04%
14.38%
20.88%
PAT Growth
-
-
-
-
-
-
-
41.86%
21.35%
-33.93%
 
EPS
-
-4.82
-5.42
-5.59
-3.31
-4.32
-1.10
5.67
4.00
3.29
4.99

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
270.04
375.32
96.15
108.01
143.35
239.13
767.41
667.00
595.28
559.31
Share Capital
21.81
21.81
14.54
12.73
12.73
12.73
12.73
12.73
12.73
12.73
Total Reserves
248.23
353.51
81.61
58.36
130.62
226.40
754.68
654.27
582.56
546.59
Non-Current Liabilities
1.35
2.46
3.57
4.50
12.07
24.51
30.20
28.21
40.54
86.43
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.25
22.65
37.08
55.09
Unsecured Loans
0.00
0.00
0.00
0.39
1.08
1.78
1.98
3.29
4.56
6.36
Long Term Provisions
1.35
1.88
2.00
1.73
1.72
1.49
3.69
2.84
2.39
2.27
Current Liabilities
13.52
105.03
102.21
109.81
120.03
156.97
225.83
208.05
210.62
127.39
Trade Payables
2.07
1.66
1.99
3.00
5.78
7.09
56.82
37.94
35.60
43.89
Other Current Liabilities
10.33
8.44
5.44
12.13
20.00
32.00
29.43
46.14
48.18
42.45
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
30.57
30.49
24.16
28.24
Short Term Provisions
1.12
94.92
94.78
94.68
94.25
117.88
109.01
93.49
102.68
12.81
Total Liabilities
284.91
482.81
201.93
222.32
275.45
420.61
1,023.44
903.26
846.44
773.13
Net Block
28.21
37.21
37.56
20.96
24.69
22.35
307.73
305.72
305.35
171.95
Gross Block
78.24
87.88
83.40
66.95
77.11
39.48
375.68
348.92
325.15
290.52
Accumulated Depreciation
50.03
50.67
45.83
45.99
52.42
17.13
67.95
43.19
19.80
118.57
Non Current Assets
28.23
137.32
41.44
25.74
115.95
22.37
349.61
322.10
318.79
291.31
Capital Work in Progress
0.00
0.00
3.55
4.77
0.00
0.02
24.74
9.72
7.20
107.01
Non Current Investment
0.00
0.00
0.00
0.00
0.00
0.00
0.07
0.07
0.07
0.00
Long Term Loans & Adv.
0.02
0.11
0.33
0.00
91.25
0.00
16.86
6.39
6.16
10.89
Other Non Current Assets
0.00
100.00
0.00
0.00
0.00
0.00
0.20
0.20
0.00
1.46
Current Assets
256.67
345.48
160.49
196.58
159.50
398.24
673.83
581.16
527.66
476.98
Current Investments
75.94
46.34
45.16
0.09
0.05
222.93
278.73
300.89
0.05
0.04
Inventories
0.71
0.00
0.02
0.14
0.00
0.00
139.47
92.51
83.46
81.81
Sundry Debtors
1.29
0.81
1.30
1.76
2.27
2.64
61.54
45.83
53.56
40.17
Cash & Bank
163.98
184.28
5.52
46.65
15.09
0.69
28.22
9.17
241.40
279.69
Other Current Assets
14.76
5.12
8.71
6.69
142.09
171.98
165.88
132.76
149.18
75.28
Short Term Loans & Adv.
11.97
108.93
99.78
141.25
140.72
169.20
115.53
99.87
108.96
34.06
Net Current Assets
243.16
240.46
58.28
86.77
39.48
241.27
448.00
373.11
317.04
349.59
Total Assets
284.90
482.80
201.93
222.32
275.45
420.61
1,023.44
903.26
846.45
773.14

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 08
Cash From Operating Activity
-115.47
-115.98
-127.54
-96.02
-134.57
-52.61
69.94
109.17
67.50
3.94
PBT
-106.08
-118.27
-122.00
-77.47
-106.40
0.16
195.53
123.07
97.58
6.36
Adjustment
-22.46
-8.09
-1.09
-2.70
-8.26
-4.87
10.32
12.91
10.98
11.22
Changes in Working Capital
6.89
11.48
-3.93
-14.70
-17.13
-32.98
-92.37
7.90
-14.36
-12.96
Cash after chg. in Working capital
-121.65
-114.88
-127.02
-94.88
-131.79
-37.70
113.47
143.88
94.20
4.63
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
6.18
-1.10
-0.52
-1.15
-2.78
-14.92
-43.54
-34.71
-26.70
-0.69
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
94.44
-247.81
-22.23
55.84
146.22
37.13
-0.61
-310.64
-38.63
-16.20
Net Fixed Assets
9.64
-0.93
-15.23
5.39
-37.61
360.92
-41.78
-26.29
-187.49
-19.37
Net Investments
-124.85
-102.35
-130.73
-53.26
117.43
21.74
-15.06
-342.87
-14.91
2.67
Others
209.65
-144.53
123.73
103.71
66.40
-345.53
56.23
58.52
163.77
0.50
Cash from Financing Activity
-1.05
395.54
145.69
34.86
2.81
4.53
-52.07
-30.39
-68.07
5.52
Net Cash Inflow / Outflow
-22.09
31.75
-4.07
-5.33
14.45
-10.94
17.26
-231.86
-39.20
-6.74
Opening Cash & Equivalents
37.02
5.27
9.35
14.68
0.23
17.89
8.69
240.55
279.75
9.78
Closing Cash & Equivalent
14.93
37.02
5.27
9.35
14.68
0.23
25.95
8.69
240.55
3.04

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
12.38
17.21
6.09
5.15
11.26
18.79
60.29
52.40
46.77
43.56
ROA
-27.37%
-34.54%
-57.51%
-28.99%
-27.07%
-3.31%
12.84%
9.97%
8.87%
22.38%
ROE
-32.56%
-50.17%
-145.90%
-67.29%
-49.27%
-4.75%
17.25%
13.81%
12.50%
32.91%
ROCE
-32.78%
-49.94%
-117.81%
-60.09%
-54.67%
0.40%
26.01%
18.19%
15.43%
37.93%
Fixed Asset Turnover
0.14
0.16
0.16
0.19
0.25
1.38
1.73
1.62
1.63
2.42
Receivable days
32.67
28.38
47.15
54.60
62.22
41.00
31.34
33.32
34.19
26.51
Inventory Days
22.12
0.00
2.53
3.83
0.00
0.00
67.71
58.98
60.29
37.16
Payable days
0.00
0.00
0.00
0.00
18.53
39.04
38.79
33.17
35.72
32.74
Cash Conversion Cycle
54.79
28.38
49.67
58.43
43.70
1.96
60.26
59.13
58.77
30.93
Total Debt/Equity
0.00
0.00
0.01
0.02
0.01
0.01
0.04
0.11
0.14
0.20
Interest Cover
-354.37
-286.20
-181.00
-81.35
-191.96
1.08
43.25
22.65
17.61
33.18

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • Suven Life Sciences - Quarterly Results
    6th May 2024, 18:45 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.